SUDDEN CARDIAC DEATH IN PATIENTS WITH DILATED CARDIOMYOPATHY

Cover Page

Abstract


The review discusses accumulated to date scientific data on dilated cardiomyopathy: causative factors, clinical manifestations, sudden cardiac death in patients with the disease and its risk-stratification in the light of National guidelines on the definition of risk and prevention of sudden cardiac death (2012). A case of a patient with dilated cardiomyopathy and high-risk of sudden cardiac death is presented.

D V Duplyakov

Email: duplyakov@yahoo.com

I V Kondratyeva

S V Garkina

  1. Национальные рекомендации по определению риска и профилактике внезапной сердечной смерти. Клиническая практика №4, 2012.
  2. Hershberger R.E., Kushner J.D., Parks S.B. Dilated Cardiomyopathy Overview. GeneReviews. Seattle (WA): University of Washington, Seattle; 1993-2007 Jul 27.
  3. Mahon N.G., Murphy R.T., MacRae C.A. et al. Echocardiographic evaluation in asymptomatic relatives of patients with dilated cardiomyopathy reveals preclinical disease. Ann Inter Med 2005;143(2):108-15.
  4. Baig M.K., Goldman J.H., Caforio A.,L. et al. Familial dilated cardiomyopathy: cardiac abnormalities are common in asymptomatic relatives and may represent early disease. J Am Coll Cardiol 1998; 31 (1): 195-201.
  5. Grunig E., Tasman J.A., Kucherer H. et al. Frequency and phenotypes of familial dilated cardiomyopathy. J Am Coll Cardiol 1998; 31 (1): 186-94.
  6. Fuster V., Gersh B.J., Giuliani E.R. et al. The natural history of idiopathic dilated cardiomyopathy. Am J Cardiol 1981; 47: 525-38.
  7. Coughlin S.S., Neaton J.D., Sengupta A. et al. Predictors of mortality from idiopathic dilated cardiomyopathy in 356,222 men screened for the Multiple Risk Factor Intervention Trial. Am J Epidemiol 1994; 139: 166-72.
  8. Dec G.W., Fuster V. Idiopathic dilated cardiomyopathy. N Engl J Med 1994; 331:1564-75.
  9. Di L.A., Secoli G., Perkan A. et al. Changing mortality in dilated cardiomyopathy. The Heart Muscle Disease Study Group. Br Heart J 1994; 72: 46-51.
  10. Sugrue D.D., Rodeheffer R.J., Codd M.B. et al. The clinical course of idiopathic dilated cardiomyopathy. A population-based study. Ann Intern Med 1992;117: 117-23.
  11. Huikuri H.V., Castellanos A., Myerburg R.J. Sudden death due to cardiac arrhythmias. N Engl J Med 2001;345:1473-82.
  12. Felker G.M., Thompson R.E., Hare J.M. et al.Underlying causes and long-term survival in patients with initially unexplained cardiomyopathy. N Engl J Med 2000; 342: 1077-84.
  13. Baba A., Yoshikawa T., Ogawa S. Autoantibodies produced against sarcolemmal Na-K-ATPase: possible upstream targets of arrhythmias and sudden death in patients with dilated cardiomyopathy. J Am Coll Cardiol 2002; 40: 1153-9.
  14. Yu H., Pei J., Lui X. et al. Calcium channel autoantibodies predicted sudden cardiac death and all-cause mortality in patients with ischemic and nonischemic chronic heart failure. Dis markers 2014. http://www.ncbi.nlm.nih.gov/pubmed/24711674.
  15. Zimetbaum P.J., Buxton A.E., Batsford W. et al. Electrocardiographic predictors of arrhythmic death and totalmortality in the multicenter unsustained tachycardia trial.Circulation 2004; 110 (7):766-9.
  16. Xiao H., Wang M., Du Y. et al. Arrhythmogenic autoantibodies against calcium channel lead to sudden death in idiopathic dilated cardiomyopathy. Eur J of Heart Failure 2011; 13: 264-70.
  17. Kimura A. Contribution of genetic factors to the pathogenesis of dilated cardiomyopathy. Circ J 2011; 75: 1756-65.
  18. Towbin J.A., Hejtmancik J.F., Brink P. et al. X-linked dilated cardiomyopathy: molecular genetic evidence of linkage to the Duchenne muscular dystrophy (dystrophin) gene at the Xp21 locus. Circulation 1993; 87: 1854-65.
  19. Hershberger R.E., Cowan J., Morales A., Siegfried J.D. Progress with genetic cardiomyopathies screening, counseling, and testing in dilated, hyper-trophic, and arrhythmogenic right ventricular dysplasia/cardiomyopathy. Circ Heart Fail 2009; 2: 253-61.
  20. Moolman-Smook J.C., Mayosi B.M., Brink P.A., Corfield V.A. Molecular genetics of cardiomyopathy: changing times, shifting paradigms. Cardiovasc J S Afr 2003;14:145-55.
  21. Mestroni L., Rocco C., Gregori D. et al. Familial dilated cardiomyopathy: evidence for genetic and phenotypic heterogeneity. J Am Coll Cardiol. 1999;34: 181-90.
  22. Bowles N.E., Bowles K.R., Towbin J.A. The final common pathway hypothesis and inherited cardiovascular disease. The role of cytoskeletal proteins in dilated cardiomyopathy. Herz 2000;25:168-75.
  23. Charron P., Arad M., Arbustini E. et al. Genetic counselling and testing in cardiomyopathies: a position statement of the European Society of Cardiology Working group on Myocardial and Pericardial Diseases. Eur J Heart 2010; 31: 2715-28.
  24. Grimm W., Michael Christ M., Jennifer Bach J. et al. Noninvasive arrhythmia risk stratification in idiopathic dilated cardiomyopathy: results of the Marburg Cardiomyopathy Study. Circulation 2003; 108: 2883-91.
  25. Grimm W., Alter P., Maisch B. Arrhythmia risk stratification with regard to prophylactic implantable defibrillator therapy in patients with dilated cardiomyopathy. Results of MACAS, DEFINITE and SCD-HeFT. Herz 2004; 29 (3): 348-52.
  26. Voss A., Schroder R., Trubner S. et al. Comparison of nonlinear methods symbolic dynamics, detrended fluctuation, and Poincare plot analysis in risk stratification in patients with dilated cardiomyopathy. CHAOS 2007; 17.
  27. Assomull R.G., Prasad S.K., Lyne J. et al. Cardiovascular magnetic resonance, fibrosis, and prognosis in dilated cardiomyopathy. J Am Coll Cardiol 2006; 48:1977-85.
  28. Bansch D., Antz M., Boczor S. et al. Primary prevention of sudden cardiac death in idiopathic dilated cardiomyopathy: the Cardiomyopathy Trial (CAT). Circulation 2002; 105:1453-58.
  29. Kadish A., Dyer A., Daubert J.P. et al. Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy. N Engl J Med 2004; 350: 2151-8.
  30. Bardy G.H., Lee K.L., Mark D.B. et al. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 2005; 352: 225-37.
  31. Parcash R., Stevenson W.G., Epstein L.M., Maisel W.H. Predicting early mortality after implantable defibrillator implantation: a clinical risk score for optimal patient selection. Am Heart J 2006; 151:397-403.
  32. Schefer T., Wolber T., Binggeli C. et al. Long-term predictors of mortality in ICD patients with non-ischaemic cardiac disease: impact of renal function. Europace. 2008 Sep;10(9):1052-9.

Views

Abstract - 101

PDF (Russian) - 155

PlumX


Copyright (c) 2014 Duplyakov D.V., Kondratyeva I.V., Garkina S.V.

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.